Holen Sie sich die Stockscreener-App
34.36
5.85%
1.90
Handel nachbörslich:
34.56
0.20
+0.58%
Alamar Biosciences Inc Aktie (ALMR) Neueste Nachrichten
Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history - Yahoo Finance Singapore
Alamar Biosciences, Inc. (ALMR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Among 197 Alzheimer’s patients, 34 of 130 blood markers changed as they received more infusions. - Stock Titan
Alamar Biosciences Study in The Lancet Neurology Finds Distinct Biomarker Responses to Lecanemab in Early Alzheimer’s Disease - Quiver Quantitative
Lancet Neurology Study Using Alamar Biosciences’ Technology - GlobeNewswire
Alamar Biosciences stock rating reiterated at Buy by TD Cowen - Investing.com South Africa
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to S&P Global BMI Index - marketscreener.com
Alamar Biosciences Shares Soar 15.90% Near 52-Week High Amid Growing Proteomics Analyst and Investor Buzz - International Business Times Australia
Why is Alamar Biosciences stock surging today? By Investing.com - Investing.com South Africa
Alamar Biosciences Soars After High-Profile Conference Buzz - TipRanks
Alamar Biosciences Tumbles As Post‑IPO Hype Fades - TipRanks
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - Kalkine
Ragusa Robert P. Acquires 5,686 Shares and 25,599 Derivative Securities of Alamar Biosciences - Kalkine Media
Alamar Biosciences (ALMR) director has no reported share holdings - Stock Titan
People in the News at Pillar Biosciences, Devyser, Alamar Biosciences - genomeweb.com
Alamar Biosciences Slides After Conference Hype Fades - TipRanks
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Alamar Biosciences, Inc. Announces Appointment of Robert Ragusa as Director and Member of Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, Effective September 1, 2026 - marketscreener.com
Alamar Biosciences appoints Robert Ragusa to Board and three committees - TradingView
Alamar Biosciences expands proteomics partnership by 86,000 samples - Investing.com Nigeria
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript - The Globe and Mail
Alamar Biosciences: Promising But Expensive Proteomics Growth - Seeking Alpha
Alamar Stock: The Content Flywheel Is More Valuable Than The Instrument (ALMR) - Seeking Alpha
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure - Sahm
Alamar Biosciences (ALMR): Yuling Luo discloses 6.4% beneficial ownership stake - Stock Titan
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - The Globe and Mail
Alamar Biosciences Q2 Results: Revenue Rises 82% To $29.4 Million - scanx.trade
Alamar Biosciences Shares (ALMR) Surge 31% as Consumables Drive Gross Margin Up - TechStock²
Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake - Stock Titan
Alamar Biosciences launches NULISAseq Immune 340 Panel for profiling - scanx.trade
Stifel raises Alamar Biosciences stock price target on earnings beat By Investing.com - Investing.com Canada
Alamar Biosciences Reports Q2 2026 Financial Results in Form 10-Q Filing - Kalkine Media
ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28 - Bitget
Alamar Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside - TradingView
Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary - TradingView
Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ... - Yahoo Finance Singapore
Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales - Yahoo Finance
Alamar Biosciences to report Q2 2026 results on August 10, 2026 - scanx.trade
Form 8K Alamar Biosciences For: 10 August By Investing.com - Investing.com Nigeria
Alamar Biosciences Q2 Earnings Call Highlights - MarketBeat
Alamar Biosciences Q2 revenue surges 82%, led by consumable demand - scanx.trade
Alamar Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Alamar Biosciences posts strong Q2 2026 revenue growth - Investing.com
Alamar Biosciences, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ALMR) 2026-08-10 - Seeking Alpha
ALAMAR BIOSCIENCES ($ALMR) Releases Q2 2026 Earnings - quiverquant.com
0.26%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):